Ontogeny, circadian rhythm pattern, and hormonal modulation of 5 alpha-dihydrotestosterone receptors in the rat pineal.
Some physiological parameters of pineal 5 alpha-dihydrotestosterone receptor in the rat such as ontogeny, circadian rhythm pattern, and its modulation by various neuropeptides and neurotransmitters which have profound influences on the pineal hormone melatonin were examined. Pineal 5 alpha-dihydrotestosterone receptors measured at different ages of the animal revealed that on day 10 both cytosolic receptor (CR) and nuclear receptor (NR) levels were high. With growth and development both groups of receptors declined and during puberty started again to rise. During adulthood both receptors were high; however, NR rose further with full maturation. Both groups of receptors showed circadian rhythmicity. While the CR was significantly higher at 6.00 h than at any time point through 24 h, the NR peaked at 18.00 h when the difference between both groups was maximum. Castration caused significant increment of NR. Treatment of castrated animals with a low dose of testosterone propionate (0.25 mg) significantly stimulated both receptor groups, while treatment with a high dose (2.5 mg) failed to do so. Treatment with various substances such as antiandrogen, opioids, neuropeptides, and neurotransmitters significantly modulated the pineal androgen receptor population: cyproterone acetate and monosodium glutamate suppressed CR; growth hormone releasing hormone increased NR; growth hormone release inhibiting hormone had no significant effects on either group of receptors; exogenous melatonin and norepinephrine increased NR; beta-endorphin increased only NR, but methionine enkephalin stimulated both, and epithalamine had no significant effects on either group of receptors, but thymosin alpha 1 increased NR.(ABSTRACT TRUNCATED AT 250 WORDS)
Gupta
D
D
Department of Diagnostic Endocrinology, University Children's Hospital, Tübingen, FRG.
Haldar
C
C
Coeleveld
M
M
Roth
J
J
D000818:Animals; D002940:Circadian Rhythm / Q000502:physiology*; D017373:Cyproterone Acetate / Q000494:pharmacology; D013196:Dihydrotestosterone; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology*; D008297:Male; D008550:Melatonin / Q000096:biosynthesis* / Q000494:pharmacology; D010870:Pineal Gland / Q000254:growth & development / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D011944:Receptors, Androgen / Q000187:drug effects*; D012970:Sodium Glutamate / Q000494:pharmacology; D013004:Somatostatin / Q000494:pharmacology; D013737:Testis / Q000502:physiology; D013739:Testosterone / Q000494:pharmacology
D006728:Hormones; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; D013739:Testosterone; D017373:Cyproterone Acetate; D013004:Somatostatin; D013007:Growth Hormone-Releasing Hormone; D008550:Melatonin; D012970:Sodium Glutamate